Kewaunee Scientific Corp KEQU
We take great care to ensure that the data presented and summarized in this overview for KEWAUNEE SCIENTIFIC CORP is accurate and up-to-date, based on a comprehensive analysis of 13F filing forms for institutional ownership and form 4 filings for insider transactions. Please note that this data may differ from other sources and should not be relied upon as the sole basis for investment decisions.
Top Institutions Holding KEQU
View all-
Northern Trust Corp Chicago, IL273KShares$15.9 Million0.0% of portfolio
-
Dimensional Fund Advisors LP Austin, TX182KShares$10.6 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA130KShares$7.59 Million0.0% of portfolio
-
Jim Simons Renaissance Technologies LLC | New York, Ny98.2KShares$5.72 Million0.01% of portfolio
-
Minerva Advisors LLC Bala Cynwyd, PA73.8KShares$4.3 Million2.18% of portfolio
-
American Century Companies Inc Kansas City, MO49.2KShares$2.87 Million0.0% of portfolio
-
De Lisle Partners LLP Poole, X044.9KShares$2.62 Million0.3% of portfolio
-
Israel Englander Millennium Management LLC | New York, Ny37.9KShares$2.21 Million0.0% of portfolio
-
O'Shaughnessy Asset Management, LLC Stamford, CT37.5KShares$2.19 Million0.01% of portfolio
-
Geode Capital Management, LLC Boston, MA23.8KShares$1.39 Million0.0% of portfolio
Latest Institutional Activity in KEQU
Top Purchases
Top Sells
About KEQU
Kewaunee Scientific Corporation designs, manufactures, and installs laboratory, healthcare, and technical furniture and infrastructure products. It operates through two segments, Domestic and International. The company's products include steel, wood, laminate furniture, fume hoods, biological safety cabinets, laminar flow and ductless hoods, adaptable modular and column systems, moveable workstations and carts, epoxy resin worksurfaces, sinks, and accessories and related design services. Its laboratory products are used in chemistry, physics, biology, and other general science laboratories in the pharmaceutical, biotechnology, industrial, chemical, commercial, educational, government, and health care markets; technical products are used in facilities manufacturing computers and light electronics and by users of computer and networking furniture; and laminate caseworks that are used in educational, healthcare, and industrial applications. The company sells its products primarily through dealers, its subidiaries, and a national distributor. Kewaunee Scientific Corporation was founded in 1906 and is headquartered in Statesville, North Carolina.
Insider Transactions at KEQU
Insider Transaction List
View all| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Jul 01
2025
|
Mandar Ranade VP-Information Technology |
SELL
Payment of exercise price or tax liability
|
Direct |
1,298
-9.3%
|
$75,284
$58.34 P/Share
|
|
Jul 01
2025
|
Ryan S. Noble VP-Sales & Marketing-Americas |
SELL
Payment of exercise price or tax liability
|
Direct |
939
-6.35%
|
$54,462
$58.34 P/Share
|
|
Jul 01
2025
|
Donald T. Gardner Iii Chief Financial Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
2,491
-12.42%
|
$144,478
$58.34 P/Share
|
|
Jul 01
2025
|
Douglas J. Batdorff VP of Manufacturing Operations |
SELL
Payment of exercise price or tax liability
|
Direct |
879
-10.91%
|
$50,982
$58.34 P/Share
|
|
Jul 01
2025
|
Thomas David Hull Iii President, CEO |
SELL
Payment of exercise price or tax liability
|
Direct |
3,483
-7.23%
|
$202,014
$58.34 P/Share
|
|
Jul 01
2025
|
Elizabeth D Phillips VP - Human Resources |
SELL
Payment of exercise price or tax liability
|
Direct |
1,196
-7.33%
|
$69,368
$58.34 P/Share
|
|
Jun 30
2025
|
Mandar Ranade VP-Information Technology |
BUY
Exercise of conversion of derivative security
|
Direct |
2,966
+17.52%
|
-
|
|
Jun 30
2025
|
Ryan S. Noble VP-Sales & Marketing-Americas |
BUY
Exercise of conversion of derivative security
|
Direct |
2,959
+16.68%
|
-
|
|
Jun 30
2025
|
Donald T. Gardner Iii Chief Financial Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
5,697
+22.12%
|
-
|
|
Jun 30
2025
|
Douglas J. Batdorff VP of Manufacturing Operations |
BUY
Exercise of conversion of derivative security
|
Direct |
3,058
+27.51%
|
-
|
|
Jun 30
2025
|
Thomas David Hull Iii President, CEO |
BUY
Exercise of conversion of derivative security
|
Direct |
12,130
+20.11%
|
-
|
|
Jun 30
2025
|
Elizabeth D Phillips VP - Human Resources |
BUY
Exercise of conversion of derivative security
|
Direct |
2,733
+14.34%
|
-
|
|
May 07
2025
|
Margaret B Pyle Director |
BUY
Grant, award, or other acquisition
|
Direct |
1,896
+50.0%
|
-
|
|
May 07
2025
|
Keith M Gehl Director |
BUY
Grant, award, or other acquisition
|
Direct |
1,896
+8.51%
|
-
|
|
May 07
2025
|
John Russell Director |
BUY
Grant, award, or other acquisition
|
Direct |
1,896
+5.22%
|
-
|
|
Apr 14
2025
|
Thomas David Hull Iii President, CEO |
SELL
Open market or private sale
|
Direct |
1,844
-4.86%
|
$59,008
$32.44 P/Share
|
|
Apr 10
2025
|
Donald T. Gardner Iii Chief Financial Officer |
SELL
Open market or private sale
|
Direct |
1,000
-6.51%
|
$35,000
$35.18 P/Share
|
|
Apr 09
2025
|
Donald T. Gardner Iii Chief Financial Officer |
SELL
Open market or private sale
|
Direct |
3,000
-8.43%
|
$111,000
$37.43 P/Share
|
|
Apr 04
2025
|
Keith M Gehl Director |
BUY
Open market or private purchase
|
Direct |
1,000
+5.13%
|
$35,000
$35.0 P/Share
|
|
Mar 26
2025
|
Donald T. Gardner Iii Chief Financial Officer |
SELL
Open market or private sale
|
Direct |
3,000
-4.82%
|
$120,000
$40.26 P/Share
|
Last 12 Months Summary
| Grant, award, or other acquisition | 5.69K shares |
|---|---|
| Exercise of conversion of derivative security | 29.5K shares |
| Open market or private purchase | 1.9K shares |
| Payment of exercise price or tax liability | 10.3K shares |
|---|---|
| Open market or private sale | 25.6K shares |
| Bona fide gift | 2.74K shares |